07:00 , Oct 24, 2016 |  BC Week In Review  |  Financial News

Endonovo Therapeutics completes private placement of senior convertible notes

ItemBodyText Endonovo Therapeutics Inc. (OTCQB:ENDV), Woodland Hills, Calif.  Business: Inflammation, Autoimmune  Date completed: 2016-10-14  Type: Private placement of senior convertible notes  Raised: $600,000  Shares outstanding prior: 122.9 million  Placement agent: Aegis Capital  Investor: Bellridge Capital ...
07:00 , Oct 24, 2016 |  BC Week In Review  |  Financial News

Endonovo Therapeutics completes private placement of senior convertible notes

ItemBodyText Endonovo Therapeutics Inc. (OTCQB:ENDV), Woodland Hills, Calif.  Business: Inflammation, Autoimmune  Date completed: 2016-10-14  Type: Private placement of senior convertible notes  Raised: $600,000  Shares outstanding prior: 122.9 million  Placement agent: Aegis Capital  Investor: Bellridge Capital ...
07:00 , Jul 25, 2016 |  BC Week In Review  |  Financial News

Endonovo Therapeutics completes private placement of senior convertible notes

Endonovo Therapeutics Inc. (OTCQB:ENDV), Woodland Hills, Calif.   Business: Inflammation, Autoimmune   Date completed: 2016-07-15   Type: Private placement of senior convertible notes   Raised: $400,000   Shares outstanding prior: 109.6 million   Placement agent:...
07:00 , Jul 25, 2016 |  BC Week In Review  |  Financial News

Endonovo Therapeutics financial update

Endonovo Therapeutics Inc. (OTCQB:ENDV), Woodland Hills, Calif.   Business: Inflammation, Autoimmune   Date announced: 2016-07-15   Note: Endonovo entered into a $9 million equity purchase agreement with Bellridge Capital.  ...